Lina Khan, FTC chair (Graeme Sloan/Sipa USA/Sipa via AP Images)

FTC chair Lina Khan to Sen­ate: Big Phar­ma M&A is still a pri­or­i­ty tar­get

As the Fed­er­al Trade Com­mis­sion has al­ready sought new ideas for an­a­lyz­ing phar­ma merg­ers, FTC chair Lina Khan re­it­er­at­ed Tues­day to a Sen­ate sub­com­mit­tee that re­view­ing Big Phar­ma merg­ers is a pri­or­i­ty.

While com­par­ing this merg­er analy­sis in the phar­ma space to the study of pub­lic util­i­ties in the 1930s “that ex­posed ram­pant fi­nan­cial fraud,” Khan said in pre­pared tes­ti­mo­ny that the com­mis­sion is go­ing to tar­get un­law­ful con­duct.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.